Literature DB >> 11716777

Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

P S Sijwali1, B R Shenai, J Gut, A Singh, P J Rosenthal.   

Abstract

In the malaria parasite Plasmodium falciparum, erythrocytic trophozoites hydrolyse haemoglobin to provide amino acids for parasite protein synthesis. Cysteine protease inhibitors block parasite haemoglobin hydrolysis and development, indicating that cysteine proteases are required for these processes. Three papain-family cysteine protease sequences have been identified in the P. falciparum genome, but the specific roles of their gene products and other plasmodial proteases in haemoglobin hydrolysis are uncertain. Falcipain-2 was recently identified as a principal trophozoite cysteine protease and potential drug target. The present study characterizes the related P. falciparum cysteine protease falcipain-3. As is the case with falcipain-2, falcipain-3 is expressed by trophozoites and appears to be located within the food vacuole, the site of haemoglobin hydrolysis. Both proteases require a reducing environment and acidic pH for optimal activity, and both prefer peptide substrates with leucine at the P(2) position. The proteases differ, however, in that falcipain-3 undergoes efficient processing to an active form only at acidic pH, is more active and stable at acidic pH, and has much lower specific activity against typical papain-family peptide substrates, but has greater activity against native haemoglobin. Thus falcipain-3 is a second P. falciparum haemoglobinase that is particularly suited for the hydrolysis of native haemoglobin in the acidic food vacuole. The redundancy of cysteine proteases may offer optimized hydrolysis of both native haemoglobin and globin peptides. Consideration of both proteases will be necessary to evaluate cysteine protease inhibitors as antimalarial drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716777      PMCID: PMC1222249          DOI: 10.1042/0264-6021:3600481

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  A novel method for predicting transmembrane segments in proteins based on a statistical analysis of the SwissProt database: the PRED-TMR algorithm.

Authors:  C Pasquier; V J Promponas; G A Palaios; J S Hamodrakas; S J Hamodrakas
Journal:  Protein Eng       Date:  1999-05

2.  A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin.

Authors:  P Raphael; Y Takakuwa; S Manno; S C Liu; A H Chishti; M Hanspal
Journal:  Mol Biochem Parasitol       Date:  2000-10       Impact factor: 1.759

3.  Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.

Authors:  B R Shenai; P S Sijwali; A Singh; P J Rosenthal
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

4.  Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1.

Authors:  M Dua; P Raphael; P S Sijwali; P J Rosenthal; M Hanspal
Journal:  Mol Biochem Parasitol       Date:  2001-08       Impact factor: 1.759

5.  Preparation and properties of apohemoglobin and reconstituted hemoglobins.

Authors:  F Ascoli; M R Fanelli; E Antonini
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2.

Authors:  P S Sijwali; L S Brinen; P J Rosenthal
Journal:  Protein Expr Purif       Date:  2001-06       Impact factor: 1.650

7.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

8.  Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase.

Authors:  F Salas; J Fichmann; G K Lee; M D Scott; P J Rosenthal
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

9.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

10.  Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis.

Authors:  B L Salmon; A Oksman; D E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  68 in total

1.  Probing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies.

Authors:  Yogesh A Sabnis; Prashant V Desai; Philip J Rosenthal; Mitchell A Avery
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

2.  Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.

Authors:  Puran S Sijwali; Kentaro Kato; Karl B Seydel; Jiri Gut; Julie Lehman; Michael Klemba; Daniel E Goldberg; Louis H Miller; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

3.  Toxopain-1 is critical for infection in a novel chicken embryo model of congenital toxoplasmosis.

Authors:  Xuchu Que; Annette Wunderlich; Keith A Joiner; Sharon L Reed
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum.

Authors:  Erica L Dahl; Jennifer L Shock; Bhaskar R Shenai; Jiri Gut; Joseph L DeRisi; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.

Authors:  Kailash C Pandey; Stephanie X Wang; Puran S Sijwali; Anthony L Lau; James H McKerrow; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

6.  Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.

Authors:  Manoj K Ramjee; Nicholas S Flinn; Tracy P Pemberton; Martin Quibell; Yikang Wang; John P Watts
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

7.  Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.

Authors:  Stephanie X Wang; Kailash C Pandey; John R Somoza; Puran S Sijwali; Tanja Kortemme; Linda S Brinen; Robert J Fletterick; Philip J Rosenthal; James H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

8.  Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.

Authors:  S Eksi; B Czesny; G-J van Gemert; R W Sauerwein; W Eling; K C Williamson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-18       Impact factor: 5.191

9.  Falcipain-1, a Plasmodium falciparum cysteine protease with vaccine potential.

Authors:  Amit Kumar; Krishan Kumar; Reshma Korde; Sunil Kumar Puri; Pawan Malhotra; Virander Singh Chauhan
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

10.  Critical role of amino acid 23 in mediating activity and specificity of vinckepain-2, a papain-family cysteine protease of rodent malaria parasites.

Authors:  Ajay Singh; Bhaskar R Shenai; Youngchool Choe; Jiri Gut; Puran S Sijwali; Charles S Craik; Philip J Rosenthal
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.